Skip to content
lifestyle.recentlegalnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ascletis Pharma Inc.
Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)
May 5, 2026
Ascletis to Present Data on Multiple Programs at the American Diabetes Association’s 2026 Scientific Sessions
April 29, 2026
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
April 26, 2026
←
Previous Page
1
2